# K252409: TearCare MGX System

- Pathway: 510(k) (Traditional)
- Applicant: Sight Sciences, Inc.
- Decided: Apr 27, 2026 after 269 days
- Product code: ORZ (Eyelid Thermal Pulsation System)
- Device class: 2
- Regulation: 21 CFR 886.5200
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 7 generations back to DEN100017 (2011). 7 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 9 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K242786: TearCare MGX System, Sight Sciences, Inc. (2025) Summary page 5.

## Most influential descendants
- K262479: TearCare System (2026), 0 descendants of its own

## Indications for use
The Sight Sciences TearCare MGX™ System is a thermal-activated gland expression therapy that improves meibomian gland function in adult patients with evaporative dry eye disease due to meibomian gland dysfunction (MGD), when used in conjunction with manual expression of the meibomian glands..

Source page: https://510kreport.com/device/K252409
Methodology: https://510kreport.com/methodology